AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17523399
Drug: Allicor (a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allicor (a long‐action garlic‐based preparation)
Trial: 15342615
Drug: Oral levosimendan
RxNorm normalized name: levosimendan
DrugBank: Levosimendan (DB00922)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral levosimendan 2 to 8 mg daily
Trial: 11532109
Drug: Control (non-ACE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (non-ACE inhibitor regimens)
Trial: 9778329
Drug: Implantable cardioverter-defibrillator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implantable cardioverter-defibrillator (ICD) therapy in NYHA class I
Trial: 9778329
Drug: Implantable cardioverter-defibrillator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implantable cardioverter-defibrillator (ICD) therapy in NYHA class II
Trial: 9778329
Drug: Implantable cardioverter-defibrillator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implantable cardioverter-defibrillator (ICD) therapy in NYHA class III
Trial: 3297521
Drug: Constant positive
RxNorm normalized name: constant albicans extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Constant positive airway pressure (CPAP) with an expiratory pressure of 12 cm H2O applied at one hour following extubation, and at daily intervals for the first five days following surgery for a continuous period of three hours
Trial: 2201225
Drug: Ketorolac 30
RxNorm normalized name: ketorolac 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac 30 mg intramuscularly followed by 10 mg 4-hourly as required
Trial: 2201225
Drug: Morphine 10
RxNorm normalized name: morphine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 10 mg intramuscularly 4-hourly as required
Trial: 31387559
Drug: Procalcitonin (PCT)
RxNorm normalized name: Procalcitonin
DrugBank: Procalcitonin (DB14812)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procalcitonin (PCT) and lung ultrasound (LUS)-guided antibiotic therapy
Trial: 31387559
Drug: Procalcitonin (PCT)
RxNorm normalized name: Procalcitonin
DrugBank: Procalcitonin (DB14812)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procalcitonin (PCT) only-guided therapy
Trial: 28203001
Drug: Bone graft
RxNorm normalized name: Bone graft material
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bone graft therapy combined with CGFs
Trial: 28203001
Drug: Bone graft
RxNorm normalized name: Bone graft material
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bone graft therapy alone
Trial: 26047892
Drug: Esmirtazapine 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esmirtazapine 3.0 mg
Trial: 26047890
Drug: Esmirtazapine (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esmirtazapine (all doses)
Trial: 21692409
Drug: Proximal steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proximal steroid injection (triamcinolone acetonide 20 mg)
Trial: 21692409
Drug: Distal steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Distal steroid injection (triamcinolone acetonide 20 mg)
Trial: 19058842
Drug: Second-generation antipsychotic
RxNorm normalized name: regenerated cellulose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second-generation antipsychotic drugs (amisulpride, clozapine, olanzapine, risperidone)
Trial: 16436844
Drug: Arndt Blocker
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arndt Blocker
Trial: 9099195
Drug: Medium-dose aspirin
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medium-dose aspirin
Trial: 9099195
Drug: Both interventions
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both interventions (low-dose and medium-dose aspirin)
Trial: 23992438
Drug: Breath Powered™
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breath Powered™ nasal delivery of 16-mg sumatriptan powder
Trial: 23992438
Drug: 20-mg liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20-mg liquid nasal spray
Trial: 23992438
Drug: 100-mg oral
RxNorm normalized name: dapsone
DrugBank: Dapsone (DB00250)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 100-mg oral tablet
Trial: 23992438
Drug: 6-mg subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-mg subcutaneous injection
Trial: 20971632
Drug: mIROX (irinotecan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mIROX (irinotecan plus oxaliplatin 85 mg/m(2))
Trial: 20971632
Drug: FUFIRI (irinotecan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FUFIRI (irinotecan 80 mg/m(2), 5‐fluorouracil 2000 mg/m(2), folinic acid 500 mg/m(2) weekly times 6)
Trial: 17194276
Drug: Citalopram 20
RxNorm normalized name: citalopram 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram 20 to 60 mg/day
Trial: 12094123
Drug: 15 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g Cr.H2O
Trial: 7572251
Drug: Daily lithium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily lithium dosing (800 mg/day)
Trial: 7572251
Drug: Every second
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Every second day lithium dosing (1200 mg/every second day)
Trial: 1971170
Drug: Ropinirol 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropinirol 0.4 mg
Trial: 1971170
Drug: Ropinirol 0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropinirol 0.8 mg
Trial: 1971170
Drug: Ropinirol 1
RxNorm normalized name: ropinirole 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropinirol 1 mg
Trial: 1971170
Drug: Ropinirol (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropinirol (all doses)
Trial: 33376
Drug: Diazepam (5‐10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (5‐10 mg)
Trial: 17458641
Drug: Bupivacaine continuous
RxNorm normalized name: Uniphyllin Continus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine continuous epidural infusion with clonidine (5 microg.ml(‐1))
Trial: 17458641
Drug: Bupivacaine continuous
RxNorm normalized name: Uniphyllin Continus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine continuous epidural infusion without clonidine (control group)
Trial: 17458641
Drug: Bupivacaine continuous
RxNorm normalized name: Uniphyllin Continus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine continuous epidural infusion with clonidine
Trial: 474042
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg cyproterone acetate
Trial: 11994349
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg cyproterone acetate
Trial: 474042
Drug: Placebo (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (3 months prior to treatment)
Trial: 25261291
Drug: lipegfilgrastim 6.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lipegfilgrastim 6.0 mg
Trial: 25261291
Drug: pegfilgrastim 6.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pegfilgrastim 6.0 mg
Trial: 22811596
Drug: Fluvastatin ER
RxNorm normalized name: fluvastatin Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin ER tablet 80 mg QD
Trial: 22811596
Drug: Fluvastatin IR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin IR capsule 40 mg BID
Trial: 19238124
Drug: Aripiprazole 15-30
RxNorm normalized name: aripiprazole 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole 15-30 mg/day
Trial: 19238124
Drug: Haloperidol 10-15
RxNorm normalized name: haloperidol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol 10-15 mg/day
Trial: 17475739
Drug: Stepped treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stepped treatment initiated with buprenorphine/naloxone
Trial: 17475739
Drug: Methadone maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone maintenance therapy
Trial: 17475739
Drug: Stepped treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stepped treatment and Methadone maintenance therapy
Trial: 15022801
Drug: Late weight-bearing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Late weight-bearing (L)
Trial: 12500987
Drug: Caffeine (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (6 mg.kg(‐1) before exercise and 0.33 mg.kg(‐1) every 15 min during exercise)
Trial: 9536227
Drug: Placebo (vehicle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (vehicle only) applied twice daily
Trial: 9536227
Drug: Calcipotriol ointment
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol ointment (50 micrograms/g) with acitretin
Trial: 9536227
Drug: Acitretin therapy
RxNorm normalized name: Acitretin
DrugBank: Acitretin (DB00459)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acitretin therapy
Trial: 30678197
Drug: Telenutrition weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telenutrition weight loss intervention with weekly support from a registered dietitian nutritionist via telephone and videoconferencing
Trial: 24594505
Drug: Lutein (21
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lutein (21 mg capsules with 250 mL of full-cream milk per day for 4 weeks)
Trial: 24594505
Drug: Placebo (with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (with 250 mL of full-cream milk per day for 4 weeks)
Trial: 22510023
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of HbA(1c) 39-46 mmol/mol (5.7-6.4%) and fasting plasma glucose 5.6-6.9 mmol/l
Trial: 22510023
Drug: Pre-diabetic individuals
RxNorm normalized name: Diabetic Tussin EX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-diabetic individuals fulfilling HbA(1c) 42-46 mmol/mol (6.0-6.4%) and fasting plasma glucose 6.1-6.9 mmol/l
Trial: 18207280
Drug: Adefovir dipivoxil
RxNorm normalized name: Adefovir Dipivoxil
DrugBank: Adefovir dipivoxil (DB00718)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Adefovir dipivoxil (ADV) plus emtricitabine (FTC) combination therapy (n=14)
Trial: 18207280
Drug: Adefovir dipivoxil
RxNorm normalized name: Adefovir Dipivoxil
DrugBank: Adefovir dipivoxil (DB00718)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Adefovir dipivoxil (ADV) plus placebo monotherapy (n=16)
Trial: 10770466
Drug: High-dose haloperidol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose haloperidol with dose reduction to achieve target plasma level of 10 ng/mL over 12 weeks
Trial: 10770466
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group maintained original high-dose haloperidol treatment
Trial: 9310019
Drug: Inhaled corticosteroid
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroid treatment, budesonide 400 micrograms twice daily
Trial: 31669136
Drug: Bolus injection
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus injection of GIP (50 pmol/kg body weight at 30 and 120 min)
Trial: 31669136
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of GIP (2 pmol.kg-1.min-1 from 30 to 180 min)
Trial: 31669136
Drug: Bolus administration
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus administration of GIP
Trial: 31669136
Drug: Continuous administration
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous administration of GIP
Trial: 27039386
Drug: E7820 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E7820 50 mg BID
Trial: 27039386
Drug: E7820 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E7820 60 mg BID
Trial: 27039386
Drug: E7820 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E7820 100 mg QD
Trial: 25208796
Drug: Whole Body
RxNorm normalized name: MaxiVision Whole Body Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole Body Vibration (WBV) therapy, 15 minutes, 3 times per week for 7 months
Trial: 20047610
Drug: Early reduction
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early reduction of corticosteroid dose (prednisone 5 mg every other day for 12 months)
Trial: 20047610
Drug: Regular-dose corticosteroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular-dose corticosteroid maintenance (prednisone progressively reduced from days 8 to 90, then maintained for 12 months)
Trial: 18692612
Drug: Regimen 1A
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen 1A (Dienogest dosage not specified)
Trial: 18692612
Drug: Regimen 2A
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen 2A (Dienogest dosage not specified)
Trial: 18692612
Drug: Regimen 2B
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen 2B (Increased Dienogest dosage)
Trial: 18692612
Drug: Regimen 2C
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen 2C (Increased Dienogest dosage)
Trial: 11936481
Drug: Subcutaneous interferon
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous interferon beta-1a (IFNbeta-1a)
Trial: 7860310
Drug: Exposed group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exposed group (cumulative radiation doses of about 500 mSv or more)
Trial: 7860310
Drug: Unexposed group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unexposed group (cumulative radiation doses less than 50 mSv)
Trial: 7051507
Drug: Cinoxacin, 250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinoxacin, 250 mg, qid for 7-14 days
Trial: 27238963
Drug: Oxycodone CR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone CR twice-daily
Trial: 23674935
Drug: Armodafinil (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Armodafinil (150 mg/day)
Trial: 23674935
Drug: CPAP treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPAP treatment after 6 weeks
Trial: 22320027
Drug: Dextromethorphan and
RxNorm normalized name: Dextromethorphan and menthol only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextromethorphan and quinidine (DMQ) at doses of 0, 30, and 60 mg
Trial: 22320027
Drug: Placebo (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0 mg DMQ)
Trial: 15459950
Drug: Adhesive tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adhesive tablets with natural active agents
Trial: 15459950
Drug: Plain tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain tablets (control)
Trial: 9571269
Drug: DAILIES(TM) daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DAILIES(TM) daily disposable soft lenses for 8 hours
Trial: 2644752
Drug: Heparin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (3 mg/kg bolus injection)
Trial: 16813738
Drug: Insulin-sensitizing treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin-sensitizing treatment strategies
Trial: 16813738
Drug: Insulin-providing treatment
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin-providing treatment strategies
Trial: 14517164
Drug: Eplerenone 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eplerenone 200 mg daily
Trial: 14517164
Drug: Eplerenone 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eplerenone 200 mg and Enalapril 10 mg daily
Trial: 8869672
Drug: Pipecuronium 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pipecuronium 0.1 mg/kg
Trial: 1642124
Drug: Standard bright
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard bright morning light therapy (1700 lx) from 0600 to 0800
Trial: 7198288
Drug: Restrictive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Restrictive treatment (bed rest in febrile stage, avoiding activities that promote headache)
Trial: 7198288
Drug: Liberal treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liberal treatment (encouraged to resume daily life as soon as possible)
Trial: 29923314
Drug: RPR 102681
RxNorm normalized name: Nxl-103 component rpr-202868
DrugBank: Linopristin (DB19296)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RPR 102681 (cholecystokinin-B antagonist)
Trial: 11584088
Drug: Weekly vitamin
RxNorm normalized name: Ezy Dose Weekly Vitamin Planner 2XL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly vitamin A and iron supplementation (4800 retinol equivalents (RE) + 120 mg Fe as FeSO(4) + 500 microg folic acid)
Trial: 11584088
Drug: Weekly iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly iron supplementation (120 mg Fe as FeSO(4) + 500 microg folic acid)
Trial: 11584088
Drug: Weekly vitamin
RxNorm normalized name: Ezy Dose Weekly Vitamin Planner 2XL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly vitamin A and iron supplementation
Trial: 9564665
Drug: GnRH-agonist therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GnRH-agonist therapy for three months
Trial: 9564665
Drug: Postoperative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative treatment for three months
Trial: 2671402
Drug: Hypertonic saline
RxNorm normalized name: ENTSOL Hypertonic Saline Nasal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertonic saline (HSL, Na 250 mEq/L, 514 mOsm)
Trial: 2671402
Drug: Lactated Ringer's
RxNorm normalized name: LACTATED RINGER'S
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lactated Ringer's solution (LR, Na 130 mEq/L, 268 mOsm)
Trial: 31796986
Drug: Tocilizumab (IL-6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocilizumab (IL-6 receptor antagonist) 8 mg/kg every 4 weeks
Trial: 31796986
Drug: Sitagliptin (DPP-4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin (DPP-4 inhibitor) 100 mg daily
Trial: 31796986
Drug: Placebo (saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (saline infusion every 4 weeks and placebo pill once daily)
Trial: 9514531
Drug: Placebo (identical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (identical capsule)
Trial: 23812094
Drug: Liraglutide 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liraglutide 3.0 mg per day
Trial: 17697065
Drug: Insulin aspart
RxNorm normalized name: Insulin Aspart
DrugBank: Insulin aspart (DB01306)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Insulin aspart (0.1 u/kg)
Trial: 17697065
Drug: Regular insulin
RxNorm normalized name: Regular insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular insulin (0.1 u/kg)
Trial: 15318285
Drug: Cyriax approach
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyriax approach (CYR) - deep friction massage and mobilisation exercises three times weekly
Trial: 15318285
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy (PT) - daily physical therapy including hot pack and short wave diathermy application
Trial: 12441023
Drug: Serotonergic antidepressants
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serotonergic antidepressants (first-line treatment)
Trial: 12441023
Drug: Selective serotonin
RxNorm normalized name: Selective serotonin (5HT1) agonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective serotonin reuptake inhibitors (SSRIs) during symptomatic luteal phase
Trial: 12441023
Drug: Slow-release formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow-release formulation of fluoxetine (taken two times during the menstrual cycle)
Trial: 12441023
Drug: New contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New contraceptive formulation
Trial: 9789122
Drug: MLT plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MLT plus aloe vera tincture (1 ml twice/day)
Trial: 9789122
Drug: MLT alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MLT alone (20 mg/day orally in the dark period)
Trial: 2553335
Drug: Nedocromil sodium
RxNorm normalized name: Nedocromil Sodium
DrugBank: Nedocromil (DB00716)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nedocromil sodium 4 mg 4-times daily
Trial: 2553335
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate 0.1 mg 4-times daily
Trial: 2553335
Drug: Placebo 2
RxNorm normalized name: Ethinyl Estradiol/Norethindrone Acetate;Placebo 20 MCG-1 MG; NA Oral Tablet, Disintegrating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo 2 puffs 4-times daily
Trial: 793481
Drug: Levamisole at
RxNorm normalized name: Levamisole
DrugBank: Levamisole (DB00848)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levamisole at a dosage of 2.5 mg/kg/day
Trial: 30366945
Drug: Low-dose radiation
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose radiation therapy (LDRT) - 1 Gray per fraction, administered six times in 2 weeks
Trial: 30366945
Drug: Low-dose radiation
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose radiation therapy (LDRT)